Webinar Summary
GLP-1 receptor agonists are transforming the landscape of obesity care, metabolic health, and chronic disease management. Yet, successful outcomes require more than medication alone. This 2-part webinar series brings together leading experts in functional medicine, nutrition, and patient care to bridge science with clinical application.
Across four engaging sessions, practitioners will gain:
- A clear understanding of GLP-1 mechanisms and multi-system effects.
- Insights into patient perspectives, knowledge gaps, and current prescribing trends.
- Practical strategies for supporting gut health, nutrient absorption, and symptom management during therapy.
- A structured framework through the Metagenics GLP-1 Companion Program, offering phased, evidence-informed support before, during, and after GLP-1 use.
With clinical pearls, case-based learning, and actionable takeaways, this series equips practitioners with the tools to optimize patient outcomes, safeguard long-term metabolic resilience, and integrate lifestyle and supplementation strategies alongside GLP-1 therapies.
Speakers and Topics:
Part I: Wednesday, September 24, 2025 11am PST
GLP-1 Receptor Agonists: Mechanisms, Clinical Applications, and Functional Integration
Presented by Jennifer Stagg, ND
Dr. Jennifer Stagg explores the science behind GLP-1 signaling, the clinical effects of GLP-1 RAs across multiple organ systems, and emerging therapeutic applications beyond diabetes and weight loss. The session will also highlight functional medicine strategies -nutrition, lifestyle, and targeted supplementation -that can complement therapy and optimize patient outcomes.
GLP-1 Trends and Perspectives: Bridging Patient Experience and Practitioner Insight
Presented by Ana Reisdorf, MS, RD
Ana Reisdorf shares her personal journey that led to the creation of the GLP-1 Hub and highlights how it has become a resource for patients and practitioners alike. Participants will explore common knowledge gaps, current trends in therapy, and the emotional realities surrounding GLP-1 use. The session also underscores the importance of proactive education and the Metagenics approach to supporting individuals before, during, and after medication use.
View Now
